Bioceres Crop Solutions (BIOX)

• Market cap: $375M
• 1 day: 1.64%
• 5 days: -6.64%
• 1 month: -4.18%
• 3 months: -24.88%
• 6 months: -41.22%
• Year to date: -54.55%
• 1 year: -54.52%
• 5 years: 19.27%
• 10 years: -35.52%

About: Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Employees: 983

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1.36% more ownership

Funds ownership: 20.57% [Q2] → 21.93% (+1.36%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

2% less funds holding

Funds holding: 48 [Q2] → 47 (-1) [Q3]

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

25% less capital invested

Capital invested by funds: $145M [Q2] → $109M (-$36.7M) [Q3]

96% less call options, than puts

Call options by funds: $3K | Put options by funds: $76K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $9.50 53% upside
• Avg. target: $11.25 82% upside
• High target: $13 110% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Austin Moeller 46% 1-year accuracy 18 / 39 met price target	53% upside $9.50	Buy Maintained	13 Nov 2024
Oppenheimer Kristen Owen 42% 1-year accuracy 13 / 31 met price target	110% upside $13	Outperform Maintained	21 Oct 2024